Help us by sharing our site |
|
|
Latest News |
GBS Early Day Motions in Parliament
Mark Durkan MP and Mike Hancock MP have each tabled EDMs - read more about them by clicking here.Please write, email or go to see your MP ...
GBSS responds to anti-screening myths
GBSS's medical advisory panel respond to common myths on why routine screening for group B Strep should not be introduced in the UK. ...
Prince Charles awards MBE to our Chief Exec
On 14 February 2012, our Chief Executive, Jane Plumb, and her family travelled to Buckingham Palace where they were all delighted for her ...
|
Find us |
Follow us |
|
|
|
Powered
by EveryClick
|
Group B Strep Support |
Tel: 0144 4416176
Fax: 0870 803 0024
E-mail: info@gbss.org.uk
Office Hours: Weekdays 9.15 am to 3.00 pm
Please note: GBSS can only provide information, not give advice. The information on this site is for information only and cannot be a substitute for a personal consultation with a qualified medical professional. If in doubt, please consult your doctor. |
Guillain-Barre Syndrome: Group B Strep may also be referred to as Beta Strep, Beta Haemolytic Strep, Strep B and Streptococcus agalactiae. GBS can also stand for Guillain-Barre Syndrome. Click here for support and information on Guillain-Barre Syndrome. |
|
Home » News and Events » Early Day Motions |
|
|
Early Day Motions
Early Day Motions (EDMs) are formal motions submitted by MPs for debate in the House of Commons. However, very few are actually debated. EDMs allow MPs to draw attention to an event or cause and they register their support by signing individual motions.
Mark Durkan MP and Mike Hancock MP have each tabled EDMs - please write, email or go to see your MP and ask him/her to sign both of these EDMs (and ask them to sign the petition too epetitions.direct.gov.uk/petitions/4854).
Group B Streptococcus - EDM62 tabled 15 May 2012 by Mark Durkan MP
That this House is concerned that the reported incidence of Group B streptococcus (GBS) infection in newborn babies in England, Wales and Northern Ireland increased by 32 per cent between 2003 and 2010; recognises that GBS is the most common cause of life-threatening infection in newborn babies in the UK; notes that without preventative action one in 1,000 newborn babies per year will develop GBS infection, of whom approximately 75 will die and 40 will survive with long-term problems; welcomes the current review of the benefits of a national screening programme being undertaken by the UK National Screening Committee; and further notes that where screening programmes have been introduced, including in the United States, Spain, Australia and France, reported cases of GBS infection in newborn babies have fallen by 86 per cent, 86 per cent, 82 per cent and 71 per cent respectively.
Group B Streptococcus (No. 2) - EDM64 tabled 15 May 2012 by Mike Hancock MP
That this House notes that Group B streptococcus (GBS) is the most common cause of life-threatening infection in newborn babies in the UK and Ireland, affecting one in 2000 babies born every year; congratulates Group B Strep Support, the UK's only charity focused on GBS infection in newborn babies, on its continued work to raise awareness of the infection, testing and prevention; recognises that a small but growing number of NHS trusts have introduced ECM testing which is twice as effective as traditional HVS testing; is concerned that prevalence of deaths relating to GBS has been steadily rising since 2003; urges the Department of Health to ensure ECM testing is available urgently; and further supports both the efficacy of screening and the need for a vaccine made available on the NHS.
There have been three previous EDMs on Group B Strep: 2003 - EDM 1211 www.parliament.uk/edm/2002-03/1211 2004 - EDM 973 www.parliament.uk/edm/2003-04/973 2005 - EDM 538 www.parliament.uk/edm/2005-06/538 |
|